Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Nebraska
University of Washington
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center